Literature DB >> 1823781

Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning.

S M Rao1, G J Leo, L Ellington, T Nauertz, L Bernardin, F Unverzagt.   

Abstract

We designed a study to assess the specific contribution of cognitive dysfunction to multiple sclerosis patients' problems in daily living. Based on the results of a comprehensive neuropsychological test battery, we classified 100 MS patients as either cognitively intact (N = 52) or cognitively impaired (N = 48). In addition to a neurologic examination, MS patients completed questionnaires on mood and social functioning, underwent a comprehensive in-home occupational therapy evaluation, and were rated by a close relative or friend regarding specific personality characteristics. While there were no significant differences between the two groups on measures of physical disability and illness duration, patients in the cognitively impaired group were less likely to be working, engaged in fewer social and avocational activities, reported more sexual dysfunction, experienced greater difficulty in performing routine household tasks, and exhibited more psychopathology than cognitively intact patients. These findings suggest that cognitive dysfunction is a major factor in determining the quality of life of patients with MS.

Entities:  

Mesh:

Year:  1991        PMID: 1823781     DOI: 10.1212/wnl.41.5.692

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  193 in total

1.  Optimism and adaptation to multiple sclerosis: what does optimism mean?

Authors:  M Fournier; D de Ridder; J Bensing
Journal:  J Behav Med       Date:  1999-08

2.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

3.  Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou; P Melville; W F Scherl; L-Y Pai; L R Muenz; D He; R H B Benedict; A Goodman; S Rizvi; S R Schwid; B Weinstock-Guttman; H J Westervelt; H Wishart
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

Review 4.  Neurorehabilitation in multiple sclerosis--what is the evidence-base?

Authors:  Jürg Kesselring
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

5.  How Do Pain, Fatigue, Depressive, and Cognitive Symptoms Relate to Well-Being and Social and Physical Functioning in the Daily Lives of Individuals With Multiple Sclerosis?

Authors:  Anna L Kratz; Tiffany J Braley; Emily Foxen-Craft; Eric Scott; John F Murphy; Susan L Murphy
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

6.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01

7.  Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.

Authors:  Kathrin S Utz; Thomas M A Hankeln; Lena Jung; Alexandra Lämmer; Anne Waschbisch; De-Hyung Lee; Ralf A Linker; Thomas Schenk
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

8.  A simple measure of cognitive reserve is relevant for cognitive performance in MS patients.

Authors:  Marida Della Corte; Gabriella Santangelo; Alvino Bisecco; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Renato Docimo; Teresa Cuomo; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

Review 9.  [Dementia as a primary symptom in late onset multiple sclerosis. Case series and review of the literature].

Authors:  T Leyhe; C Laske; G Buchkremer; H Wormstall; H Wiendl
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

10.  An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.

Authors:  Nancy D Chiaravalloti; Nancy B Moore; Olga M Nikelshpur; John DeLuca
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.